ArticleCancer immunology, immunotherapy : CII2016

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.

Kristoffer Sand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.